- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03838302
Evaluation of Sexual Functions With Validated Measurement Scale After Transvaginal Extraction of Tissue by Laparoscopic Surgery With Uterus Preservation (FSF-TVE) (FSF-TVE)
Evaluation of Female Sexual Functions With Validated Measurement Scale (Female Sexual Function Index) After Transvaginal Versus Trocars Extraction of Tissue by Laparoscopic Surgery With Uterus Preservation
The retrieval of tissues removed by laparoscopic surgery larger than trocars caliber, with preservation of the uterus, required for a long time intraperitoneal electromechanical morcellation, until the Food and Drug Administration expressed concern about intraperitoneal dissemination of malignant cells, in the case of unrecognized sarcomas.
Transvaginal contained tissue extraction via a posterior colpotomy and manual morcellation in the bag is one of the possible alternatives.
Available data suggested the effectiveness and safety of this technique, also in terms of time and costs, without a increased risk intra and post-operative complications.
The available evidence shows the lack of sequelae also on fertility and sexual function.
Nevertheless, sexual function has never been evaluated qualitatively in all its aspects nor quantitatively with a validated measurement scale, which can allow us to inform the consequences on the real risk of implications on sexual function determined by vaginal incision. In view of these elements, the aim of the investigator's study is to compare patients in whom laparoscopic tissue removal has been carried out with posterior colpotomy or without it with removal from the trocars.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Varese, Italy, 21100
- "Filippo Del Ponte" Hospital
-
Principal Investigator:
- Fabio Ghezzi, Prof.
-
Principal Investigator:
- Jvan Casarin, Dr.
-
Principal Investigator:
- Simone Garzon, Dr.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Benign uterine and adnexal pathology
- Preservation of the uterus
- Sexually active women
- Premenopausal women
Exclusion Criteria:
- Pelvic inflammatory disease, endometriosis and pre-existing dyspareunia or chronic pelvic pain of any origin
- Previous Hysterectomy
- Other gynecological and non-gynecological (chronic endocrine, metabolic, autoimmune, neoplastic diseases, psychopathology, mental and sensory-motor disabilities) comorbidities
- Language barrier
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Transvaginal retrieval
Transvaginal retrieval via a posterior colpotomy for removing tissue by laparoscopic surgery with uterus preservation
|
Transvaginal retrieval via a posterior colpotomy for removing tissue by laparoscopic surgery with uterus preservation
|
Transabdominal retrieval
Transabdominal retrieval via trocar for removing tissue by laparoscopic surgery with uterus preservation
|
Transabdominal retrieval via trocar for removing tissue by laparoscopic surgery with uterus preservation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Female Sexual Function Index
Time Frame: Change from baseline (before surgery) and 2 months after surgery
|
The Female Sexual Function Index (FSFI) is a brief questionnaire measure of sexual functioning in women. Score range: minimum 2.0, maximum 36.0. Higher values represent a better outcome. |
Change from baseline (before surgery) and 2 months after surgery
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- FSF-TVE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transvaginal Tissue Extraction
-
Rigshospitalet, DenmarkCompletedTransvaginal Ultrasound Scan
-
Ain Shams Maternity HospitalActive, not recruitingInduction of Labor | Transvaginal Ultrasound: Cervical Sliding SignEgypt
-
Cairo UniversityCompletedTrans Abdominal Ultrasound | Transvaginal Ultrasound | Lower Uterine Segment ThicknessEgypt
-
Tri-Service General HospitalEnrolling by invitationTooth Extraction | Alveolar Ridge Augmentation | Connective Tissue | Membranes; RetainedTaiwan
-
Centro Specialistico Odontoiatrico, RomeRecruitingBone Augmentation | Dental Implant | Soft Tissue Augmentation | Tooth Extraction Status NosItaly
-
Altamash Institute of Dental MedicineJinnah Postgraduate Medical CentreRecruitingPost-Extraction Socket Hemostasis | Post-Extraction Socket Pain Relief | Post-Extraction Socket HealingPakistan
-
Tufts UniversityActive, not recruitingTooth ExtractionUnited States
-
Melaka Manipal Medical CollegeCompletedTooth ExtractionMalaysia
-
The University of Texas Health Science Center at...Completed
-
Thrombotargets Europe S.LCompleted
Clinical Trials on Transvaginal tissue retrieval via a posterior colpotomy
-
Universitair Ziekenhuis BrusselHopital Antoine BeclereRecruitingBreast Cancer FemaleBelgium
-
Turtle Health, Inc.WithdrawnFertility IssuesUnited States
-
Turtle Health, Inc.CompletedFertility RiskUnited States
-
Coloplast A/SCompletedPelvic Organ ProlapseUnited States, France, Belgium, Netherlands, Australia, Canada
-
BiogenCompletedMultiple SclerosisUnited States